CDKN1B Val 109 Gly variant is not related to risk of prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CDKN1B Val 109 Gly variant is not related to risk of prostate cancer

Published:2019-06-30 Issue:10 Volume:120 Page:18346-18356
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Zhu Lijie¹,Wang Jun¹,Yue Chuang²,Yuan Wei³^ORCID,Zhang Wei⁴,Shi Li²,Mi Yuanyuan¹,Wu Xingyu²,Zhang Li‐Feng²^ORCID,Zuo Li²

Affiliation:

1. Department of Urology Affiliated Hospital of Jiangnan University Wuxi China

2. Department of Urology The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou Jiangsu China

3. Department of Cardiology Taizhou People's Hospital Taizhou Jiangsu China

4. Department of Oncology Taizhou People's Hospital Taizhou Jiangsu China

Funder

National Natural Science Foundation of China

Wuxi Municipal Bureau on Science and Technology

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.29144

Reference34 articles.

1. Cancer statistics, 2018

2. MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls

3. NCCN Asia Consensus Statement prostate cancer

4. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Genetic Variations in CDK2, CCNE1 and p27^KIP1 in Prostate Cancer;Cancer Genomics - Proteomics;2022

2. Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-02-12

3. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer;Scientific Reports;2021-01-14

4. NEAT1 promotes retinoblastoma progression via modulating miR‐124;Journal of Cellular Biochemistry;2019-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3